LENZ insider transaction filings
LENZ Therapeutics, Inc. — 34 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen LENZ transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Guerard Frederic — Director | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Scheiner Zachary — Director | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | George Jeffrey P. — Director | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Drapkin Kimberlee C — Director | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Thunen Shelley B — Director | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | MCCOLLUM JAMES W — Director | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | George Jeffrey P. — Director | Purchase (P): 5,592 @ $8.92 | EDGAR |
| 2026-03-30 | 4 | Schimmelpennink Evert B. — President, CEO and Secretary, Director | Purchase (P): 28,089 @ $8.95 | EDGAR |
| 2026-03-30 | 4 | Chevallard Daniel R. — Chief Financial Officer | Purchase (P): 7,500 @ $8.57 | EDGAR |
| 2026-01-06 | 4 | Odrich Marc — Chief Medical Officer | Grant/award (A): 84,200 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Olsson Shawn — Chief Commercial Officer | Grant/award (A): 84,200 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Schimmelpennink Evert B. — President, CEO and Secretary, Director | Grant/award (A): 358,100 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Chevallard Daniel R. — Chief Financial Officer | Grant/award (A): 84,200 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Olsson Shawn — Chief Commercial Officer | Option exercise (M): 10,000 @ $2.08 · Sale (S): 4,212 @ $25.74 · Sale (S): 5,788 @ $26.37 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | MCCOLLUM JAMES W — Director | Purchase (P): 10,500 @ $22.79 | EDGAR |
| 2025-11-07 | 4 | Chevallard Daniel R. — Chief Financial Officer | Purchase (P): 20 @ $22.71 · Purchase (P): 2,178 @ $22.76 | EDGAR |
| 2025-10-02 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 49,701 @ $45.35 · Sale (S): 34,405 @ $45.35 · Sale (S): 83,066 @ $46.41 · Sale (S): 57,502 @ $46.41 · Sale (S): 177 @ $47.01 · Sale (S): 123 @ $47.01 | EDGAR |
| 2025-09-22 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 49,479 @ $41.59 · Sale (S): 24,370 @ $41.59 · Sale (S): 40,907 @ $43.00 · Sale (S): 20,148 @ $43.00 · Sale (S): 268 @ $43.30 · Sale (S): 132 @ $43.30 | EDGAR |
| 2025-08-26 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 20,493 @ $40.03 · Sale (S): 10,076 @ $40.03 · Sale (S): 5,668 @ $40.59 · Sale (S): 2,809 @ $40.59 · Sale (S): 50,270 @ $39.53 · Sale (S): 24,760 @ $39.53 · +6 more | EDGAR |
| 2025-08-19 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 145,051 @ $39.50 · Sale (S): 69,949 @ $39.50 · Sale (S): 30,628 @ $38.56 · Sale (S): 15,085 @ $38.56 | EDGAR |
| 2025-07-14 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 191,376 @ $34 | EDGAR |
| 2025-07-01 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 200,000 @ $30.46 | EDGAR |
| 2025-06-20 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 100,000 @ $29.95 · Sale (S): 100,877 @ $30.35 · Sale (S): 133,924 @ $30.25 | EDGAR |
| 2025-06-12 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner Versant Venture Capital VII, L.P. — 10% owner Versant Ventures VII GP, L.P. — 10% owner Versant Ventures VII GP-GP, LLC — 10% owner | Sale (S): 350,000 @ $29 | EDGAR |
| 2025-06-11 | 4 | Guerard Frederic — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Scheiner Zachary — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | George Jeffrey P. — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Drapkin Kimberlee C — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Thunen Shelley B — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | MCCOLLUM JAMES W — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Olsson Shawn — Chief Commercial Officer | Option exercise (M): 1,400 @ $2.08 · Option exercise (M): 1,400 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Schimmelpennink Evert B. — President, CEO and Secretary, Director | Option exercise (M): 4,200 @ $1.04 · Option exercise (M): 4,200 (derivative) @ $0 | EDGAR |
Recent 8-K events — LENZ Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-08 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-30 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LENZ returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →